In 2019, the top 10 therapeutic classes accounted for 76.8% of all scripts and 79.6% of all costs. An understanding of the most-utilized and highest-ranked classes of medications by cost can drive intervention opportunities and benchmark targeted efforts for pharmacy program management. Year-over-year trend changes can also guide decision-making and identify drug class utilization and cost outliers that may warrant further evaluation for appropriateness and safety.
Watch the video blog here.